Abstract
Increasing evidence suggests that a small set of cellular genes appear to be targets for genetic alterations that contribute to the neoplastic transformation of cells. These genes, termed protooncogenes, appear to play a crucial role in normal cellular growth or differentiation since they are highly conserved in nature, being detected in species as divergent as yeast, Drosophila, and humans. Recent identification of a number of these genes as encoding for putative growth factors (sis,hst, int-2), growth factor receptors (neu, erb B, fms), proteins involved in the regulation of transmembrane signal transduction (ras), nuclear regulatory proteins (myc, myb, fos, jun), tyrosine kinases (src) and serine/threonine kinases (raf, mos) has served to substantiate this idea.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Land, H., Parada, L., and Weinberg, R. A., 1983, Cellular oncogenes and multistep carcinogenesis, Science 44: 771–778.
Varmus, H. E., 1984, The molecular genetics of cellular oncogenes, Annu. Rev. Genet. 18: 553–612.
Bishop, J. M., 1985, Viral oncogenes, Cell 42: 23–38.
Weinberg, R. A., 1985, The action of oncogenes in the cytoplasm and nucleus, Science 230: 770–776.
Bishop, J. M., 1987, The molecular genetics of cancer, Science 235: 305–311.
Balmain, A., Ramsden, M., Bowden, G. T., and Smith, J., 1984, Activation of the mouse cellular Harvey-ras gene in chemically induced benign skin papillomas, Nature (Lond.) 307: 658–660.
Guerrero, I., Villasante, A., Corces, V., and Pellicer, A., 1984, Activation of the c-K-ras oncogene by somatic mutation in mouse lymphomas induced by gamma radiation, Science 225: 1159–1162.
Zarbl, H., Sukumar, S., Arthur, A. V., Martin-Zanca, D., and Barbacid, M., 1985, Direct mutagenesis of H-ras-I oncogenes by nitroso-methylurea during initiation of mammary carcinogenesis in rats, Nature (Lond.) 315: 382–385.
Bizub, D., Wood, A. W., and Skalka, A. M., 1986, Mutagenesis of the Ha-ras oncogene in mouse skin tumors induced by polycyclic aromatic hydrocarbons, Proc. Natl. Acad. Sci. USA 83: 6048–6052.
Brodeur, G. M., Seeger, R. C., Schwab, M., Varmus, H. E., and Bishop, J. M., 1984, Amplification of N-myc in untreated neuroblastomas correlates with advanced disease stage, Science 224: 1121–1124.
Seeger, R. C., Brodeur, G. M., Sather, H., Dalton, A., Siegel, S. E., Wong, K. Y., and Hammond, D., 1985, Association of multiple copies of the N-myc oncogene with rapid progression of neuroblaste, N. Engl. J. Med. 313: 1111–1116.
Vousden, K. H., and Marshall, C. J., 1984, Three different activated ras genes in mouse tumors; evidence for oncogene activation during progression of a mouse lymphoma, EMBO J. 3: 913–917.
Tainsky, M. A., Cooper, C. S., Giovanella, B. C., and Vande Woude, G. F., 1984, An activated N-ras gene: Detected in late but not early passage human PA1 teratocarcinoma cells, Science 225: 643–645.
Land, H., Parada, L. F., and Weinberg, R. A., 1983, Tumorigenic conversion of primary embryo fibroblasts requires at least two cooperating oncogenes, Nature (Land.) 304: 596–602.
Spandidos, D. A., and Wilkie, N. M., 1984, Malignant transformation of early passage rodent cells by a single mutated oncogene, Nature (Lond.) 310: 469–475.
Barrett, J. C., Oshimura, M., and Koi, M., 1987, Role of oncogenes and tumor supressant genes in a multistep model of carcinogenesis, in: Symposium on Fundamental Cancer Research, Vol. 38 (F. Becker, ed.), pp. 45–56.
Gazdar, A. F., Camey, D. N., Nau, M. M., and Minna, J. D., 1985, Characterization of variant subclasses of cell lines derived from small cell lung cancer having distinctive biochemical, morphological, and growth properties, Cancer Res. 45: 2924–2930.
Escot, C., Theillet, C., Lidereau, R., Spyratos, F., Champema, M. H., Gest, J., and Callahan, R., 1986, Genetic alteration of the c-myc proto-oncogene (MYC) in human primary breast carcinomas, Proc. Natl. Acad. Sci. USA 83: 4834–4838.
Barletta, C., Pelicci, P-G., Kenyon, L. C., Smith, S. D., and Dalla-Favera, R., 1987, Relationship between the c-myb locus and the 6q-chromosomal aberration in leukemias and lymphomas, Science 235: 1064–1067.
Slamon, D. J., Clark, G. M., Wong, S. G., Levin, W. J., Ullrich, A., and McGuire, W. L., 1987, Human breast cancer: correlation of relapse and survival with amplification of the HER-2/neu oncogene, Science 235: 177–182.
Konopka, J. B., Watanabe, S. M., and Witte, O. N., 1984, An alteration of the human c-abl protein in K562 leukemia cells unmasks associated tyrosine kinase activity, Cell 37: 1035–1042.
Shtivelman, E., Lifshitz, B., Gale, R. P., and Canaani, E., 1985, Fused transcript of abl and ber genes in chronic myelogenous leukaemia, Nature (Land.) 315: 550–554.
Konopka, J. B., Clark, S., McLaughlin, J., Nitta, M., Kato, Y., Strife, A., Clarkson, B., and Witte, O. N., 1986, Variable expression of the translocated c-abl oncogene in Philadelphia-chromosome-positive B-lymphoid cell lines from chronic myelogenous leukemia patients, Proc. Natl. Acad. Sci. USA 83: 4049–4052.
Tsujimoto, Y., and Croce, C. M., 1986, Analysis of the structure, transcripts, and protein products of bcl-2, the gene involved in human follicular lymphoma, Proc. Natl. Acad. Sci. USA 83: 5214–5218.
Shih, C., Shilo, B., Goldfarb, M. P., Dannenberg, A., and Weinberg, R. A., 1979, Passage of phenotypes of chemically transformed cells via transfection of DNA and chromatin, Proc. Natl. Acad. Sci. USA 76: 5714–5718.
Bos, J. L., Fearon, E. R., Hamilton, S. R., Verlaan-deVries, M., van Boom, J. H., van der Eb, A. J., and Vogelstein, B., 1987, Prevalence of ras gene mutations in human colorectal cancers, Nature (Lond.) 327: 293–297.
Verlaan-deVries, M., Boggard, M., van den Elst, H., van Boom, J. H., van der Eb, A. J., and Bos, J. L., 1986, A dot-blot screening procedure for mutated ras oncogenes using synthetic oligonucleotides, Gene 50: 313–320.
Forrester, K., Almoguera, C., Han, K., Grizzle, W. E., and Perucho, M., 1987, Detection of high incidence of K-ras oncogenes during human colon tumorigenesis, Nature (Lond.) 327: 298–303.
Ochiya, T., Fujiyama, A., Fukushige, S., Hatada, I., and Matsubara, K., 1986, Molecular cloning of an oncogene from a human hepatocellular carcinoma, Proc. Natl. Acad. Sci. USA 83: 4993–4997.
Sakamoto, H., Mori, M., Taira, M., Yoshida, T., Matsukawa, S., Shimizu, K., Sekiguchi, M., Terada, M., and Sugimura, T., 1986, Transforming gene from human stomach cancers and a noncancerous portion of stomach mucosa, Proc. Natl. Acad. Sci. USA 83: 3997–4001.
Martin-Zanca, D., Hughes, S. H., and Barbacid, M., 1986, A human oncogene formed by the fusion of truncated tropomyosin and protein kinase sequences, Nature (Lond.) 319: 743–748.
Fusco, A., Arieco, M., Santoro, M., Berlingieri, M. T., Pilotti, S., Pierotti, M. A., Della Porta, G., and Vecchio, G., 1987, A new oncogene in human thyroid papillary carcinomas and their lymph-nodal metastases, Nature (Lond.) 328: 170–172.
Schechter, A. L., Stern, D. F., Vaidyanathan, L., Decker, S. J., Drebin, J. A., Greene, M. I., and Weinberg, R. A., 1984, The neu oncogene: An erb-B-related gene encoding a 185,000-Mr tumour antigen, Nature (Lond.) 312: 513–516.
Sukumar, S., 1987, Involvement of oncogenes in carcinogenesis, in: Cellular and Molecular Biology of Experimental Mammary Cancer ( D. Medina, W. Kidwell, G. Heppnar, and E. Anderson, eds.), pp. 381–398, Plenum, New York.
Fasano, O., Birnbaum, D., Edlund, L., Fogh, J., and Wigler, M., 1984, New human genes detected by a tumorigenicity assay, Mol. Cell. Biol. 4: 1695–1705.
Bos, J. L., Toksoz, D., Marshall, C. J., Verlaan-deVries, M., Veeneman, G. H., van der Eb, A. J., van Boom, J. H., Janssen, J. W. G., and Steenvoorden, C. M., 1985, Amino-acid substitutions at codon 13 of the N-ras oncogene in human acute myeloid leukaemia, Nature (Lond.) 315: 726–730.
Ananthaswamy, H. N., Price, J. E., Goldberg, L. H., and Straka, C., 1987, Simultaneous transfer of tumorigenic and metastatic phenotypes by transfection with genomic DNA from a human cutaneous squamous cell carcinoma, Proc. Am. Assoc. Cancer Res. 28: 69.
Reynolds, S. H., Stowers, S. J., Patterson, R., Maronpot, R. R., Aaronson, S. A., and Anderson, M. W., 1987, Activated oncogenes in B6C3F1 mouse liver tumors: Implications for risk assessment, Science 237: 1309–1316.
Tainsky, M. A., Shamanski, F. L., Blair, D., and Vande Woude, G., 1987, Human recipient cell for oncogene transfection studies, Mol. Cell. Biol. 7: 1280–1284.
Sukumar, S., Notano, V., Martin-Zanca, D., and Barbacid, M., 1983, Induction of mammary carcinomas by nitroso-methyl-urea involves malignant activation of H-ras-1 locus by single point mutations, Nature (Lond.) 306: 658–661.
Barbacid, M., 1987, ras Genes, Annu. Rev. Biochem. 56: 780–813.
Quintanilla, M., Brown, K., Ramsden, M., and Balmain, A., 1986, Carcinogen-specific mutation and amplification of Ha-ras during mouse skin carcinogenesis, Nature (Lond.) 322: 78–80.
Reynolds, S. H., Stowers, S. J., Maronpot, R. R., Anderson, M. W., and Aaronson, S. A., 1986, Detection and identification of activated oncogenes in spontaneously occurring benign and malignant hepatocellular tumors of the B6C3F1 mouse, Proc. Natl. Acad. Sci. USA 83: 33–37.
Brown, K., Quintanilla, M., Ramsden, M., Kerr, I. B., Young, S., and Balmain, A., 1986, v-ras Genes from harvey and balb murine sarcoma viruses can act as initiators of two-stage mouse skin carcinogenesis, Cell 46: 447–456.
Bargmann, C. I., Hung, M. C., and Weinberg, R. A., 1986, Multiple independent activations of the neu oncogene by a point mutation altering the transmembrane domain of p185, Cell 45: 649–657.
Sawey, M. J., Hood, A. T., Burns, F. J., and Garte, S. J., 1987, Activation of myc and ras oncogenes in primary rat tumors induced by ionizing radiation, Mol. Cell. Biol. 7: 932–935.
Haseman, J. K., Huff, J., and Boorman, G. A., 1984, Use of historical control data in carcinogenicity studies in rodents, Toxicol. Pathol. 12: 126–135.
Fox, T. R., and Watanabe, P. G., 1985, Detection of a cellular oncogene in spontaneous liver tumors of B6C3F1 mice, Science 228: 596–597.
Stowers, S. J., Glover, P. L., Boone, L. R., Maronpot, R. R., Reynolds, S. H., and Anderson, M. W., 1987, Activation of the K-ras proto-oncogene in rat and mouse lung tumors induced by chronic exposure to tetranitromethane, Cancer Res. 47: 3212–3219.
Wiseman, R. W., Stowers, S.J., Miller, E. C., Anderson, M. W., and Miller, J. A., 1986, Activating mutations of the c-Ha-ras proto-oncogene in chemically induced hepatomas of the male B6C3F1 mouse, Proc. Natl. Acad. Sci. USA 83: 5285–5289.
Balmain, A., and Pragnell, I. B., 1983, Mouse skin carcinomas induced in vivo by chemical carcinogens have a transforming Harvey-ras oncogene, Nature (Lond.) 303: 72–74.
McMahon, G., Hanson, L., Lee, J., and Wogan, G. N., 1986, Identification of an activated c-Ki-ras oncogene in rat liver tumors induced by aflatoxin B1, Proc. Natl. Acad. Sci. USA 83: 9418–9422.
Guerrero, I., Calzada, P., Mayer, A., and Pellicer, A., 1984, A molecular approach to leukemogenesis: mouse lymphomas contain an activated c-ras gene, Proc. Natl. Acad. Sci. USA 81: 202–205.
Guerrero, I., Villasante, A., Corces, V., and Pellicer, A., 1985, Loss of the normal N-ras allele in a mouse thymic lymphoma induced by a chemical carcinogen, Proc. Natl. Acad. Sci. USA 82: 7810–7814.
Eva, A., and Trimmer, R. W., 1986, High frequency of c-K-ras activation in 3-methylcholanthreneinduced mouse thymomas, Carcinogenesis 7: 1931–1933.
Tennant, R. W., Margolin, B. H., Shelby, M. D., Zeiger, E., Haseman, J. K., Spalding, J., Caspary, W., Resnick, M., Stasiewicz, S., Anderson, B., and Minor, R., 1987, Prediction of chemical carcinogenicity in rodents from in vitro genetic toxicity assays, Science 236: 933–941.
Ocadiz, R., Sauceda, R., Cruz, M., Graef, A. M., and Ganglio, P., 1987, High correlation between molecular alterations of the c-myc oncogene and carcinoma of the uterine cervix, Cancer Res. 47: 4173–4177.
Yokota, J., Tsunetsugu-Yakota, Y., Battifora, H., Le Fevre, C., and Cline, M. J., 1986, Alterations of myc, myb, and Ha-ras proto-oncogenes in cancers are frequent and show clinical correlation, Science 231: 261–265.
Nau, M. M., Carney, D. N., Battey, J., Johnson, B., Little, C., Gazdar, A., and Minna, J. D., 1984, Amplification, expression and rearrangement of c-myc and N-myc oncogenes in human lung cancer, Curr. Topics Microbiol. Immunol. 113: 172–177.
Nau, M. M., Brooks, B. J., Battey, J., Sausville, E., Gazdar, A. F., Kirsch, I. R., McBride, O. W., Bertness, V., Hollis, G. F., and Minna, J. D., 1985, L-myc, a new myc-related gene amplified and expressed in human small cell lung cancer, Nature (Lond.) 318: 69–73.
Wong, A. J., Ruppert, J. M., Eggleston, J., Hamilton, S. R., Baylin, S. B., and Vogelstein, B., 1986, Gene amplification of c-myc and N-myc in small cell carcinoma of the lung, Science 233: 461–464.
King, C. R., Kraus, M. H., and Aaronson, S. A., 1985, Amplification of a novel V-erbB-related gene in a human mammary carcinoma, Science 229: 974–976.
Semlea, K., Kamata, N., Toyoshima, K., and Yamamoto, T., 1985, A v-erbB-related protooncogene, e-erbB-2, is distinct from the c-erbB- I /epidermal growth factor-receptor gene and is amplified in a human salivary gland adenocarcinoma, Proc. Natl. Acad. Sci. USA 82: 6497–6501.
Pelicci, P-G., Lanfrancone, L., Brathwaite, M. D., Wolman, S. R., and Dalla-Favera, R., 1984, Amplification of the c-myb oncogene in a case of human acute myelogenous leukemia, Science 224: 1117–1121.
Slamon, D. J., deKemion, J. B., Verma, I. M., and Cline, M. J., 1984, Expression of cellular oncogenes in human malignancies, Science 224: 256–262.
Wang, L-C., Vass, W., Gao, C., and Chang, K. S. S., 1987, Amplification and enhanced expression of the c-Ki-ras-2 protooncogene in human embryonal carcinomas, Cancer Res. 47: 4192–4198.
Fujita, J., Srivastava, S. K., Kraus, M. H., Rhim, J. S., Tronick, S. R., and Aaronson, S. A., 1985, Frequency of molecular alterations affecting ras protooncogenes in human urinary tract tumors, Proc. Natl. Acad. Sci. USA 82: 3849–3853.
Croce, C. M., Thierfelder, W., Erikson, J., Nishikura, K., Finan, J., Lenoir, G. M., and Nowell, P. C., 1983, Transcriptional activation of an unrearranged and untranslocated c-myc oncogene by translocation of a cX locus in Burkitt lymphoma cells, Proc. Natl. Acad. Sci. USA 80: 6922–6926.
Dalla-Favera, R., Bregni, M., Erikson, J., Patterson, D., Gallo, R. C., and Croce, C. M., 1982, Human c-myc oncogene is located on the region of chromosome 8 that is translocated in Burkitt lymphoma cells, Proc. Natl. Acad. Sci. USA 79: 7824–7827.
Erikson, J., Nishikura, K., Ar-Rushdi, A., Finan, J., Emanuel, B., Lenoir, G., Nowell, P. C., and Croce, C. M., 1983, Translocation of an immunoglobulin K locus to a region 3’ of a unnrearranged c-myc oncogene enhances c-myc transcription, Proc. Natl. Acad. Sci. USA 80: 7581–7585.
Cory, S., Gerondakis, S., and Adams, J. M., 1983, Interchromosomal recombination of the cellular oncogene c-myc with the immunoglobulin heavy chain locus in murine plasmacytomas is a reciprocal exchange, EMBO J. 2: 697–703.
Shen-Ong, G. L. C., Keath, E. J., Piccoli, S. P., and Cole, M., 1982, Novel myc oncogene RNA from abortive immunoglobulin-gene recombination in mouse plasmacytomas, Cell 31: 443–452.
Stanton, L. W., Watt, R., and Marcu, K. B., 1983, Translocation, breakage, and truncated transcripts of c-myc oncogene in murine plasmacytomas, Nature (Lond.) 303: 401–406.
Erikson, J., Finger, L., Sun, L., Ar-Rushdi, A., Nishikura, K., Minowada, J., Finan, J., Emanuel, B. S., Nowell, P. C., and Croce, C. M., 1986, Deregulation of c-myc by translocation of the a-locus of the T-cell receptor in T-cell leukemias, Science 232: 884–886.
Moroy, T., Marchio, A., Etiemble, J., Trepo, C., Tiollais, P., and Buendia, M-A., 1986, Rearrangement and enhanced expression of c-myc in hepatocellular carcinoma of hepatitis virus infected woodchucks, Nature (Lond.) 324: 276–279.
Tsujimoto, H., Yunis, J., Onovato-Showe, L., Erikson, J., Nowell, P. C., and Croce, C. M., 1984, Molecular cloning of the chromosomal breakpoint of B-cell lymphomas and leukemias with the t(11;I4) chromosome translocation, Science 224: 1403–1406.
Groffen, J., Stephenson, J. R., Heisterkamp, N., de Klein, A., Bartram, C. R., and Grosveld, G., 1984, Philadelphia chromosomal breakpoints are clustered within a limited region, bcr, on chromosome 22, Cell 36: 93–99.
Clark, S. S., McLaughlin, J., Crist, W. M., Champlin, R., and Witte, O. N., 1987, Unique forms of the abl tyrosine kinase distinguish Ph’-positive CML from Ph1-positive ALL, Science 235: 85–88.
Stanton, V. P., and Cooper, G. M., 1987, Activation of human raf transforming genes by deletion of normal amino-terminal coding sequences, Mol. Cell. Biol. 7: 1171–1179.
Bos, J. L., Verlaan-deVries, M., van der Eb, A. J., Janssen, J. W. G., Delwel, R., Lownberg, B., and Colly, L. P., 1987, Mutations in N-ras predominate in acute myeloid leukemia, Blood 69: 1237–1241.
Hirari, H., Kobayashi, Y., Mano, H., Hagiwara, K., Mani, Y., Omine, M., Mizoguchi, H., Nishida, J., and Takaku, F., 1987, A point mutation at codon 13 of the N-ras oncogene in myelodysplastic syndrome, Nature (Lond.) 327: 430–432.
Shimizu, K., Nakatsu, Y., Sekiguchi, M., Hokamura, K., Tanaka, K., Terada, M., and Sugimura, T., 1985, Molecular cloning of an activated human oncogene, homologous to v-raf, from primary stomach cancer, Proc. Natl. Acad. Sci. USA 82: 5641–5645.
Eva, A., and Aaronson, S. A., 1985, Isolation of a new human oncogene from a diffuse B-cell lymphoma, Nature (Lond.) 316: 273–275.
Pulciani, S., Sakano, T., Ohnishi, K., Anastasi, A. M., Pecorelli, A., Fiorucci, G., Oppi, C., Rossi, G. B., and Bonavida, B., 1987, Detection of a transforming gene in spontaneous reticulum cell sarcoma of SJL/J mice: Genetically linked and host-dependent neoplasia, Cancer Res. 47: 523–526.
Sukumar, S., Peroantoni, A., Reed, C., Rice, J. M., and Wenk, M. L., 1986, Activated K-ras and N-ras oncogenes in primary renal mesenchymal tumors induced in F344 rats by methyl(methoxymethyl)nitrosamine, Mol. Cell. Biol. 6: 2716–2720.
McMahon, G., Hanson, L., Lee, J., and Wogan, G. N., 1986, Identification of an activated c-Ki-ras oncogene in rat liver tumors induced by aflatoxin B1, Proc. Natl. Acad. Sci. USA 83: 9418–9422.
Farber, E., 1984, Cellular biochemistry of the stepwise development of cancer with chemicals. Cancer Res. 44: 5463–5474.
Garte, S. J., Hood, A. T., Hochwait, A. E., D’Eustachio, P., Snyder, C. A., Segal, A., and Albert, R. E., 1985, Carcinogen specificity in the activation of transforming genes by direct-acting alkylating agents, Carcinogenesis 6: 1709–1712.
Stowers, S. J., Wiseman, R. W., Ward, J. M., Miller, C. M., Miller, J. A., Anderson, M. W., and Eva, A., 1988, Detection of activated proto-oncogenes in N-nitrosodiethylamine-induced liver tumors: A comparison between B6C3F1 mice and Fischer 344 rats, Carcinogenesis 9: 271–276.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1989 Plenum Press, New York
About this chapter
Cite this chapter
Anderson, M.W., Reynolds, S.H. (1989). Activation of Oncogenes by Chemical Carcinogens. In: Sirica, A.E. (eds) The Pathobiology of Neoplasia. Springer, Boston, MA. https://doi.org/10.1007/978-1-4684-5523-6_15
Download citation
DOI: https://doi.org/10.1007/978-1-4684-5523-6_15
Publisher Name: Springer, Boston, MA
Print ISBN: 978-1-4684-5525-0
Online ISBN: 978-1-4684-5523-6
eBook Packages: Springer Book Archive